Omeros (OMER) Current Taxes (2021 - 2026)
Omeros recorded quarterly Current Taxes of $1.1 million in Q1 2026, little changed quarter-over-quarter from $1.1 million in Q4 2025.
Omeros' Current Taxes history runs 6 years deep, the most recent figure standing at $1.1 million for Q1 2026.
- In Q1 2026, Current Taxes changed N/A year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $1.1 million (changed N/A YoY), while the FY2025 annual figure was $1.1 million, up 1983.64% from the prior year.
- Current Taxes came in at $1.1 million for Q1 2026 at Omeros, roughly flat from $1.1 million in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $4.9 million in Q4 2022 to a low of $55000.0 in Q4 2024.
- A 5-year average of $2.1 million and a median of $1.2 million in 2023 frame the typical range for Current Taxes.
- Across the five-year window, Current Taxes surged 1341.12% in 2022 and surged 1983.64% in 2025, its largest moves.
- Omeros' Current Taxes stood at $4.9 million in 2022, then tumbled by 74.79% to $1.2 million in 2023, then plunged by 95.52% to $55000.0 in 2024, then soared by 1983.64% to $1.1 million in 2025, then changed by 0.0% to $1.1 million in 2026.
- According to Business Quant data, Current Taxes over the past three periods registered $1.1 million, $1.1 million, and $55000.0 for Q1 2026, Q4 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 10,460.56 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 19.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | 1.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.15 Mn |
| Dec 31, 2025 | 1.15 Mn |
| Dec 31, 2024 | 55,000.00 |
| Sep 30, 2023 | 1.23 Mn |
| Jun 30, 2023 | 1.23 Mn |
| Mar 31, 2023 | 4.87 Mn |
| Dec 31, 2022 | 4.87 Mn |
| Dec 31, 2021 | 338,000.00 |